Follow The Filings

CVX Chevron

Energy, filed as CHEVRON CORP NEW (COM), Equity As of 2026 Q3 among managers we track Quote on Google Finance, opens in a new tab

Bought by 2 managers in 2026 Q2, sold by 4

  • 3 Owners
  • #46
  • Max 3.2%
  • Master 0.82%
  • $33M
  • 3 reduce

In 2026 Q3 Torray Investment Partners, Kentucky Trust, and Murphy Pohlad trimmed Chevron.

Who owns this now

Largest portfolio weights among holders, up to 3.2% (Torray Investment Partners). Not free-float ownership.

  1. Torray Investment Partners Reduce 3.2%
  2. Kentucky Trust Co. Reduce 1.9%
  3. Murphy Pohlad Reduce 1.8%

Who owns CVX

Sorted by value, long equity only, as of 2026 Q3.

History
Torray Investment Partners 3.2% Reduce −11.4% 119,943 $24M History
Murphy Pohlad, Murphy Pohlad Asset Management 1.8% Reduce −0.8% 25,626 $5.2M History
Kentucky Trust Co., Kentucky Trust 1.9% Reduce −2.9% 18,157 $3.7M History

3 current, options excluded

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by CVX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CVX insider trades
  • None no insider bought on the open market
  • $468M sold by 8 insiders outside a trading plan
  • $179M sold by 4 insiders under 10b5-1 plans
  1. R. Hewitt Pate Chief Legal Officer
    Planned sale
    $9.8M 43,100 shares at $226.59 83% of stake
    Traded Oct 19–20 Filed Oct 21
    ↗
  2. R. Hewitt Pate Chief Legal Officer
    Sale
    $507K 2,470 shares at $205.11 19% of stake
    Traded Aug 18 Filed Aug 20
    ↗
  3. Andrew Benjamin Walz President, DM&C
    Sale
    $3.4M 16,800 shares at $201.06 100% of stake
    Traded Aug 17 Filed Aug 19
    ↗
  4. Michael K Wirth CEO
    Sale
    $63.6M 317,100 shares at $200.46 92% of stake
    Traded Aug 14 Filed Aug 18
    ↗
  5. Jeff B Gustavson President, New Energies
    Sale
    $2.7M 14,044 shares at $194.95 79% of stake
    Traded Aug 11 Filed Aug 13
    ↗
  6. Michael K Wirth CEO
    Sale
    $1M 5,547 shares at $187.00 17% of stake
    Traded Aug 5 Filed Aug 7
    ↗
  7. John B Hess Director
    Sale
    $157M 810,665 shares at $194.12
    Traded Aug 3 Filed Aug 5
    ↗
  8. John B Hess Director
    Sale
    $73.4M 380,000 shares at $193.20 58% of stake
    Traded May 20 Filed May 22
    ↗
  9. John B Hess Director
    Sale
    $36M 195,000 shares at $184.78 23% of stake
    Traded May 6 Filed May 8
    ↗
  10. R. Hewitt Pate Chief Legal Officer
    Planned sale
    $8.6M 40,200 shares at $213.30 82% of stake
    Traded Mar 30 Filed Apr 1
    ↗
  11. R. Hewitt Pate Chief Legal Officer
    Planned sale
    $9.1M 47,200 shares at $192.12 85% of stake
    Traded Mar 6 Filed Mar 10
    ↗
  12. Mark A Nelson Vice Chairman
    Sale
    $26.2M 139,600 shares at $187.92 93% of stake
    Traded Mar 2 Filed Mar 4
    ↗
  13. Michael K Wirth CEO
    Planned sale
    $51.6M 272,624 shares at $189.35 90% of stake
    Traded Mar 2 Filed Mar 4
    ↗
  14. Andrew Benjamin Walz President, DM&C
    Sale
    $2.2M 11,600 shares at $188.58 100% of stake
    Traded Mar 2 Filed Mar 4
    ↗
  15. R. Hewitt Pate Chief Legal Officer
    Planned sale
    $17.5M 93,475 shares at $187.67 92% of stake
    Traded Feb 27–Mar 2 Filed Mar 3
    ↗

Also filed in the last 12 months, not counted as buying or selling: 94 option exercises, 38 share withholdings for taxes, 12 stock grants, 11 sales back to the company, 5 other transactions, and 3 gifts.

Congress

28 members of Congress traded CVX in the last three years: 23 buys and 37 sales. 26 members listed it in 2025 annual reports.

All Congress trades
  1. Pete Sessions R-TX-17 Sell $15K–$50K Oct 14 filed Oct 27
  2. Kevin Hern R-OK-1Joint Partial sale $15K–$50K Sep 23 filed Oct 13
  3. Maria Elvira Salazar R-FL-27 Buy $1K–$15K Sep 2 filed Oct 7
  4. John Boozman R-ARJoint Buy $1K–$15K Jul 2 filed Aug 17
  5. Michael Guest R-MS-3Spouse Sell $1K–$15K Dec 16, 2025 filed Aug 14
  6. Alan Armstrong R-OK Sell $1K–$15K Mar 27 filed Jul 21

SEC filings

Recent issuer filings from EDGAR, 14 shown.

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
8-K 5.02 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.02 Filing Doc
8-K 5.07 Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02 Filing Doc
DEFA14A Filing Doc
DEFA14A Filing Doc

Source: SEC EDGAR submissions, updated about 3 hours ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $196.91B $193.41B $184.43B
Gross profit * $77.72B $74.21B $76.22B
Gross margin * 39.5% 38.4% 41.3%
Net income $21.37B $17.66B $12.3B
Net margin * 10.9% 9.1% 6.7%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $41.13B $40.91B $38.55B
Total non-current assets * $220.5B $216.03B $285.46B
Total assets $261.63B $256.94B $324.01B
Total current liabilities $32.26B $38.56B $33.39B
Total non-current liabilities * $67.44B $65.22B $98.45B
Total equity $160.96B $152.32B $186.45B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $35.61B $31.49B $33.94B
Cash from investing -$15.23B -$8.94B -$15.91B
Cash from financing -$30.11B -$23.47B -$19.06B
Net change in cash -$9.85B -$1.01B -$0.977B

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.